Red biotechnology, also known as medical biotechnology, refers to the branch of biotechnology that focuses on the application of genetic engineering and molecular biology to develop innovative medical products and treatments. Unlike green biotechnology, which revolves around agriculture, or white biotechnology, which centers on industrial applications, red biotechnology is dedicated to advancements in healthcare. This field encompasses the development of pharmaceuticals, diagnostic tests, gene therapies, and vaccines. Researchers in red biotechnology work on understanding and manipulating biological processes at the molecular level to create novel medical solutions. Examples of red biotechnology applications include the production of genetically engineered drugs, stem cell therapies, and personalized medicine tailored to an individual's genetic makeup. The continuous progress in red biotechnology holds promise for groundbreaking advancements in medical science and the improvement of healthcare outcomes.
Title : Why do 90% of the drugs fail in development? An analysis of 82+ submissions; and a case study of immunotherapy
Narendra Chirmule, Indian Institute of Technology (IIT), India
Title : Eliminating implant failure in humans with nano chemistry: 45,000 cases and counting
Thomas J Webster, Brown University, United States
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Steps and strides: Cross-species insights into movement and injury
Babak Faramarzi, Western University of Health Sciences, United States
Title : Ancient wisdom, modern science: Biotech services transforming ayurveda
Prashant Sakharam Bhokardankar, Datta Meghe Ayurvedic Medical College Hospital and Research Centre, India
Title : Scientist’s computational lawyer
Julia Sidorova, Instituto Carlos III de Salud (CIBER-EHD), Spain